HIGH-CONCENTRATIONS OF PLASMA-IMMUNOREACTIVE INHIBIN DURING NORMAL-PREGNANCY IN WOMEN

The plasma inhibin concentrations in 190 normal pregnant women at 5–40 weeks gestation and in 4 puerperal women were measured by a specific RIA for human inhibin. The average plasma inhibin concentrations in pregnant women throughout pregnancy (minimum, 2.25 ± 0.48 IU/mL at 17 weeks gestation; maximum, 24.15 ± 6.99 IU/mL at 39 weeks gestation) were much higher than those in nonpregnant women with a normal menstrual cycle (0.46 ± 0.04 IU/mL in the midfollicular phase and 2.02 ± 0.47 IU/mL in the midluteal phase). The inhibin concentrations were already high at 5 weeks gestation (7.54 ± 1.10 IU/mL) and rose to peak at 8–10 weeks gestation. The concentrations then decreased and remained relatively low during 14–30 weeks gestation, but rose again during the third trimester. The inhibin concentrations decreased to undetectable levels after delivery. Immunoreactive inhibin was demonstrated in the corpus luteum and term placental extracts, and the dose-response curves were parallel to an inhibin preparation from human follicular fluid. Immunoreactive inhi-bin concentrations were also high in both the umbilical vein and artery (7.77 ± 0.80 and 7.84 ± 0.78 IU/mL, respectively). These observations suggest that both the corpus luteum and placenta are likely sources of inhibin. © 1990 by The Endocrine Society.